Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Alcohol warning on analgesics

This article was originally published in The Tan Sheet

Executive Summary

Alcohol warning on analgesics: In a March 25 response to FDA's recent letter on its plans for a proposal on alcohol warnings for all analgesics, the Nonprescription Drug Manufacturers Association says it forwarded the agency's letter to its internal analgesic task force, covered the subject in a March 18 special issue of its Active Member Report, and provided the letter to the NDMA executive committee and board of directors on March 20 and 21. In the March 14 letter, FDA said the upcoming proposal will "encourage" manufacturers to "voluntarily" implement the warning prior to a final rule ("The Tan Sheet" March 25, p. 1)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel